You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 9, September 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Neurodevelopmental and Respiratory Outcome in Early Childhood After Human Surfactant Treatment

Yvonne E. Vaucher, MD; T. Allen Merritt, MD; Mikko Hallman, MD; Anna-Liisa Jarvenpaa, MD; Aimee M. Telsey, MD; Barbara L. Jones, RN, MN, CPNP

Am J Dis Child. 1988;142(9):927-930.


Abstract

• We assessed postnatal growth, neurodevelopmental outcome, and occurrence of respiratory illnesses In 46 infants of very low birth weight who were enrolled in a randomized, controlled, bicenter clinical trial of human surfactant treatment for respiratory distress syndrome. No long-term adverse effects of human surfactant treatment were detected between control and human surfactant–treated infants with respect to growth, neurologic, or developmental outcome. Infants with chronic lung disease, regardless of treatment group, had poorer growth and were more likely to have neurodevelopmental abnormalities at 12 to 24 months of age.

(AJDC 1988;142:927-930)



Author Affiliations

From the Divisions of Neonatology, Departments of Pediatrics, University of California-San Diego (Drs Vaucher, Merritt, and Telsey and Ms Jones), and University of Helsinki (Drs Hallman and Jarvenpaa).


Footnotes

Accepted for publication June 2, 1988.

Reprint requests to UCSD Medical Center, H-814-J, Department of Pediatrics, Division of Neonatology, 225 W Dickinson, San Diego, CA 92103 (Dr Vaucher).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Surfactant-Replacement Therapy for Respiratory Distress in the Preterm and Term Neonate
Engle and and the Committee on Fetus and Newborn
Pediatrics 2008;121:419-432.
ABSTRACT | FULL TEXT  

School-age Follow-up of Prophylactic Versus Rescue Surfactant Trial: Pulmonary, Neurodevelopmental, and Educational Outcomes
Sinkin et al.
Pediatrics 1998;101 :e11-e11.
ABSTRACT | FULL TEXT  

A Longitudinal Study of Developmental Outcome of Infants With Bronchopulmonary Dysplasia and Very Low Birth Weight
Singer et al.
Pediatrics 1997;100:987-993.
ABSTRACT | FULL TEXT  

Pulmonary Surfactant Therapy
Jobe
NEJM 1993;328:861-868.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.